scorecardresearch
Add as a preferred source on Google
Saturday, January 31, 2026
TopicCholesterol drugs

Topic: cholesterol drugs

Demand soars for twice-a-year jab to lower bad cholesterol. Here’s how it works

Inclisiran was developed by Novartis & launched in India in January this year under brand name Leqvio. Cardiologist vouch for benefits, say it has been a useful addition to therapies.

2 jabs a year to keep bad cholesterol at bay — breakthrough treatment to launch in India this month

Novartis India, the company that has the import and marketing permission for Inclisiran, refused to divulge the price of the drug in India, but market sources say it is going to be Rs 1.2 lakh per jab.

Does egg consumption lead to diabetes? A new study claimed so but here’s the full picture

Eggs are one of the most nutritious foods providing best quality protein, all essential amino acids, vitamins, and minerals. This high-protein food is a must in low-carb diets.

Higher apolipoprotein B shortens lifespan, increases risk of heart disease, finds Lancet study

The study says apolipoprotein B, a protein involved in the metabolism of lipids, contributes to formation of fatty acid deposits on arteries which may result in heart disease.

Hospitalised Covid patients on some cholesterol drugs half as likely to die, finds study

Statins are commonly given to cholesterol patients & help lower risk of cardiovascular disease. Studies show it likely reduces mortality in hospitalised Covid cases, experts call for trials.

Cholesterol drugs could reduce risk of lethal prostate cancer in men by 24%, study says

According to the study, statins reduce the risk of developing a lethal form of the disease but they do not affect the overall rates of prostate cancer in men.

On Camera

What the last decade reveals about India’s economic path

In India, there has been remarkable certainty on taxes, particularly as the government has largely focused on slashing taxes, both direct and indirect, rather than increasing them.

Market Swings in India Surge From Historic Low as Budget Nears

New Delhi: Indian stocks are seeing a resurgence of volatility just weeks after being dubbed the world’s calmest equity market, with growing skepticism sparking...

During Op Sindoor, hackers targeted NSE website 40 crore times in 10 minutes, Exchange CEO says

NSE CEO Ashishkumar Chauhan was speaking at Off The Cuff event hosted by ThePrint's Editor-in-Chief Shekhar Gupta. He said that NSE, on average, sees 20 crore cyberattacks each day.

Swiss report should now close Op Sindoor debate. Knowing when to stop the fight is key too

The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.